Bora Biologics, a contract development and manufacturing organization based in the U.S., has entered a long-term collaboration with Protect Animal Health, a biotechnology company focused on antibody solutions for veterinary medicine. The partnership, announced on October 4, 2026, will support the development and manufacturing of several antibody-based programs targeting both U.S. and global animal health markets.
Read More
Under this agreement, Protect Animal Health plans to advance at least three antibody programs with Bora Biologics, which includes two monoclonal and one bispecific antibody initiative. This marks Bora Biologics' first engagement in the animal health sector, expanding its capabilities into this area.
The collaboration encompasses support from cell line development through process development, scale-up, and manufacturing. Bora Biologics aims to leverage its expertise and infrastructure across the United States and Taiwan in this endeavor. Protect Animal Health selected Bora Biologics based on its CHO-K1 cell line technology, development experience, and integrated manufacturing capabilities suitable for both U.S. and international markets.
Haolin Sung, President of Protect Animal Health, stated the company is establishing a robust pipeline of veterinary antibody products and believes Bora Biologics offers the necessary technical and manufacturing depth for advancing their projects. Jennifer Kuan, CEO of Bora Biologics, emphasized that this partnership marks a significant expansion for their company into animal health and highlights their proficiency in antibody development.
The collaboration will not only support Protect Animal Health's existing pipeline but also enables Bora Biologics to assist other animal health programs requiring expertise in antibody development and quality manufacturing. Steven Huang, Global BD Director of Bora Biologics, noted that the partnership illustrates Bora's potential to apply its skills across both human and animal health sectors.
Bora Biologics specializes in providing comprehensive services for biologics development, including cell line development and manufacturing support from facilities in the U.S. and Taiwan. Protect Animal Health focuses on innovative biologics and advanced therapeutic solutions, building a diversified pipeline designed to meet unmet medical needs in the veterinary market.